Search

A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.

… Wednesday, August 23, 2023 Highlights New research shows how a key immune pathway — the STING pathway — which normally defends the body against viruses and cancer, actually dampens immune responses and helps cancer spread. When STING is persistently activated, it leads to desensitization and a rewiring

In honor of Minority Cancer Awareness Month, Dr. Brown shared information about cancer disparities, the importance of cancer screening, and MSK's health equity work.

… Friday, April 30, 2021 In honor of Minority Cancer Awareness Month, MSK’s Chief Health Equity Officer Dr. Carol Brown spoke with NY1 reporter Ruschell Boone on April 29 about cancer health disparities , the role fear plays in cancer screening hesitancy, and the importance of not putting off cancer screening

Twelve students have successfully defended their dissertations and will receive their PhD degrees at Commencement on May 14.

… Thursday, May 8, 2014 Twelve students at the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences have successfully defended their dissertations. As part of Memorial Sloan Kettering’s 35th annual academic convocation on May 14, Gerstner Sloan Kettering will award PhD degrees to Minna Balbas,

Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.

… Friday, May 15, 2020 Summary Hundreds of Memorial Sloan Kettering employees who have recovered from COVID-19 have stepped forward to donate their plasma to treat patients through a clinical trial led by Esperanza Papadopoulos. As the world struggles with the epic challenge of the COVID-19 pandemic, employees

Hepatic arterial infusion chemotherapy given to colorectal cancer patients with liver metastases extends their survival by almost two years, according to a large retrospective study from Memorial Sloan Kettering recently published in the JCO.

… Thursday, October 12, 2017 The largest retrospective study ever done to assess the impact of hepatic arterial infusion (HAI) chemotherapy on survival outcomes in people with colorectal cancer with liver metastases has shown that the addition of HAI extends survival by almost two years . The results of

Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of the curriculum.

… Tuesday, October 14, 2014 Gerstner Sloan Kettering Graduate School student stipends are supported by a variety of sources including philanthropic fellowships. Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of

To help some patients to overcome leukemia, MSK doctors are calling upon patients’ microbiomes — the vast ecosystems of microorganisms that live within us, especially the gut. These microbes appear to help some patients recover from bone marrow and stem cell transplants.

… Friday, April 1, 2022 Bridget Anderson and Charlie Gerstung at the Red Rocks Amphitheatre in Colorado. After recovering from her cord blood transplant, Bridget Anderson, shown here with now-husband Charlie Gerstung, was finally able to travel to Red Rocks in Colorado. Summary To help some patients to

Seven GSK PhD students were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).

… Wednesday, September 13, 2023 This past academic year, seven PhD students enrolled at  the Gerstner Sloan Kettering Graduate School of Biomedical Sciences  (GSK) were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science

Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American Society of Hematology 2024 annual meeting.

… Saturday, December 7, 2024 Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported  results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression to multiple myeloma, a type of rare, incurable blood cancer affecting the

About a third of patients with metastatic breast cancer don’t respond well to the standard anti-estrogen therapies; to find ways to better treat those patients, Memorial Sloan Kettering Cancer Center is studying three new selective estrogen receptor down-regulators (SERDs) in clinical trials.

… Thursday, June 23, 2016 While breast cancer is the most common cancer occurring in women worldwide, it is no longer considered to be a single disease. The presence or absence of an estrogen receptor, a progesterone receptor, and a protein called HER2 distinguish the subtypes of invasive breast cancer